kt 5823 has been researched along with corticosterone in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 27,121 | 124 | 6,622 |
| Protein | Taxonomy | kt 5823 (IC50) | corticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, J; Nair, N; Nguyen, L; O'Donnell, JM; Pan, J; Sun, J; Xu, Y; Zhang, C; Zhang, H | 1 |
1 other study(ies) available for kt 5823 and corticosterone
| Article | Year |
|---|---|
Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.
Topics: Animals; Carbazoles; Cells, Cultured; Corticosterone; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 2; Dose-Response Relationship, Drug; Female; Hippocampus; Imidazoles; Male; Mice; Phosphodiesterase Inhibitors; Pregnancy; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction; Stress, Psychological; Triazines | 2013 |